1. Muhvić D. et al, The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers, Mediators of inflammation, vol 10, 155-162, 2001. 

2. Tak P.P. & Firestein G.S.,NF-kB:a key role in inflammatory diseases, J Clin Invest, vol 107, 7-11, 2001.

3. Heumann D. and Glauser M, Pathogenesis of sepsis, Sientific American,Science&Medicine 1994, 28-

37. 

4. Glauser MP, Pathophysiologic basis of sepsis:Considerations for future strategies of intervention, Critical Care Medicine 2000;28:S4-S8.

 5. Weideman B. et al., Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures, Infection &Immunity, vol 62, 4709-4715, 1994.

6. Takeda K & Akira S, Toll-like receptors in inate immunity, International Immunology 17(1):1-14, 2005.

7.B.Weidemann et al.Specific binding of soluble  peptidoglycan and muranyldipeptide to CD14 on human monocytes,Infection &Immunity, Mart 1997.

8.Parrillo JE,Pathogenetic mechanisms of septic shock,The new england journal of medicine,vol. 328, No20,1993

9.AG Tsitou et al ,Septic shock;current pathogenetic concepts from clinical perspective,Med SciMonit,2005;11(3);RA76-85

10.R.Dziarsky,Review:Recognition of bacterial peptidoglycan by the innate immune system,Cell.Mol.Life Sci.60 (2003) 1793-1804